[1]
Rahman MH, Akter R, Behl T, et al. COVID-19 Outbreak and Emerging Management through Pharmaceutical Therapeutic Strategy. Curr Pharm Des 2020; 26(41): 5224-40.
[2]
Shawon J, Akter Z, Hossen MM, et al. Current Landscape of Natural Products against Coronaviruses: Perspectives in COVID-19 Treatment and Anti-viral Mechanism. Curr Pharm Des 2020; 26(41): 5241-60.
[3]
Wilkin P, Al-Yozbaki M, George A, Gupta GK, Wilson C. The Undiscovered Potential of Essential Oils for Treating SARS-CoV-2 (COVID-19). Curr Pharm Des 2020; 26(41): 5261-77.
[4]
Pamuru RR, Ponneri N, Damu AG, Vadde R. Targeting Natural Products for the Treatment of COVID-19 – An Updated Review. Curr Pharm Des 2020; 26(41): 5278-85.
[5]
Sohrab SS, Suhail M, Kamal MA, Ahmad F, Azhar EI. The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2. Curr Pharm Des 2020; 26(41): 5286-92.
Current Pharmaceutical Design
Title:Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part-I)
Volume: 26 Issue: 41
Author(s): Mohammad Amjad Kamal and Md. Asaduzzaman Khan
Affiliation:
Export Options
About this article
Cite this article as:
Kamal Amjad Mohammad and Khan Asaduzzaman Md., Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part-I), Current Pharmaceutical Design 2020; 26 (41) . https://dx.doi.org/10.2174/138161282641201126124050
DOI https://dx.doi.org/10.2174/138161282641201126124050 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
32
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Global Clinical Trials for the Treatment of TB with Thioridazine
Recent Patents on Anti-Infective Drug Discovery Glycyrrhizin as a Potential Treatment for the Novel Coronavirus (COVID-19)
Mini-Reviews in Medicinal Chemistry Emergence of a New Zoonotic COVID-19 that Creates a Pandemic: Update on Current Pharmacotherapeutics and Future Prospective of Plasma Therapy
Coronaviruses Natural Products, a Potential Therapeutic Modality in Management and Treatment of nCoV-19 Infection: Preclinical and Clinical Based Evidence
Current Pharmaceutical Design Off Label Medication to Combat COVID-19: Review Results to Date
Coronaviruses Covid-19: Urgent Call to Action
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Inhibitor Design for SARS Coronavirus Main Protease Based on “Distorted Key Theory”
Medicinal Chemistry COVID-19 and Neurology: An Emerging Association
Infectious Disorders - Drug Targets Identification of Main Protease of Coronavirus SARS-CoV-2 (M<sup>pro</sup>) Inhibitors from <i>Melissa officinalis</i>
Current Drug Discovery Technologies Advances of Inorganic Materials in the Detection and Therapeutic Uses against Coronaviruses
Current Medicinal Chemistry Molecular Docking Demonstration of the Liquorice Chemical Molecules on the Protease and ACE2 of COVID-19 Virus
Current Enzyme Inhibition Repositioning of Drugs as a Promising Strategy to Fight COVID-19
Coronaviruses Structure Based Drug Design Approach to Identify Potential SARS-CoV-2 Polymerase Inhibitors
Coronaviruses Hepatic Involvement as Hyperbilirubinemia in Patients with COVID-19: Case Series from Iran
Infectious Disorders - Drug Targets Dental Care during the COVID-19 Pandemic
Coronaviruses Gibbs Sampling Shows Possibilities of B-Cell Epitope Signatures
Protein & Peptide Letters Natural Derived Nasal Spray; A Proposed Approach for COVID-19 Disease Control
Infectious Disorders - Drug Targets Tocilizumab: From Rheumatic Diseases to COVID-19
Current Pharmaceutical Design Trypsin-Chymotrypsin Inhibitors from Vigna mungo Seeds
Protein & Peptide Letters The Effectiveness and Safety of Remdesivir for the Treatment of Patients With COVID-19: A Systematic Review and Meta-Analysis
Anti-Infective Agents